US Patent 12011425 Hepatitis B antiviral agents

Is a

Patent

Patent attributes

Patent Applicant

Enanta Pharmaceuticals

Current Assignee

Enanta Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120114250

Patent Inventor Names

Hui Cao0

Byung-Chul Suh0

Jorden Kass0

Wei Li0

Xuri Gao0

Yat Sun Or0

Xiaowen Peng0

Yao-Ling Qiu0

Date of Patent

June 18, 2024

Patent Application Number

181012580

Date Filed

January 25, 2023

Patent Citations

‌

US Patent 8101643 Benzimidazole derivatives

‌

US Patent 7232825 Phenylaminopyrimidine derivatives and methods of use

‌

US Patent 7312214 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors

‌

US Patent 7411003 Inhibition of Hepatitis B virus by cyclohexenone compounds from

‌

US Patent 7615569 Inhibitors of ion channels

‌

US Patent 7741494 Histone deacetylase inhibitors

‌

US Patent 9938301 Dihydropyrimido fused ring derivative as HBV inhibitor

‌

US Patent 10179131 Hepatitis B antiviral agents

...

Patent Primary Examiner

CPC Code

Patent abstract

The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 12011425 Hepatitis B antiviral agents

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 12011425 Hepatitis B antiviral agents